Trial Profile
Comparison of the efficacy and safety of dabigatran and warfarin in patients with atrial fibrillation using data from real world practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Stroke
- Focus Therapeutic Use
- 10 Sep 2015 Subgroup analysis; elderly patients ≥75 years (n=15,918) results published in the Thrombosis and Haemostasis.
- 07 May 2014 New trial record